T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals

Abstract

T cell subset dysregulation in ACPA+ individuals predates the onset of IA, predicts the risk and faster progression to IA, with added value over previously published clinical predictors of progression.